RCL three-lens brief
Evidence-based stock research on RCL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $338.11 — 17% above current (27 analysts). · Negative free cash flow last quarterly (-$194.88M).
- Analyst mean target $338.11 — 17% above current (27 analysts).
- Negative free cash flow last quarterly (-$194.88M).
- Debt-to-equity of 217% — balance-sheet-heavy.
- Earnings scheduled 2026-07-28.
RCL closed at $287.87 (-0.07%) as of 2026-07-10. Market cap: $77.21B. P/E (trailing) 17.6. Price is above the 50-day MA and above the 200-day MA. Positives: analyst mean target $338.11 — 17% above current (27 analysts).. Concerns: negative free cash flow last quarterly (-$194.88M).; debt-to-equity of 217% — balance-sheet-heavy.. Last quarter: Revenue $4.45B, net income $941.00M, free cash flow -$194.88M. Watching for: 2026-07-28 earnings release (17 days out).
Why three lenses on RCL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine RCLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/RCL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath RCL brief"></iframe>